RXRX earnings: a negative outcome, -6.8%

On August 9, 2022, Recursion Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.8% in the window around the event. It had already run +10.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.